Credit Suisse Upgrades Eli Lilly (LLY) to Outperform
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,180.16 -2.25%
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
30 Buy, 5 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Earlier, Credit Suisse upgraded Eli Lilly (NYSE: LLY) from Neutral to Outperform.
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $42.40 yesterday.
For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.
Shares of Eli Lilly closed at $42.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly files six lawsuits over illegal sales of unapproved retatrutide
- Eli Lilly selects Veeva Vault CRM for global deployment
- The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
